Human immunodeficiency virus in the parturient

Journal of Clinical Anesthesia

Volumn 15, Issue 3, 2003, Pages 224-233

  Kuczkowski, Krzysztof M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

Acquired immune deficiency syndrome; AIDS; Anesthetic implications; HIV infection; Human immunodeficiency virus; Pregnancy

Indexed keywords

ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; ETHAMBUTOL; GANCICLOVIR; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; ISONIAZID; LAMIVUDINE; NEVIRAPINE; PENTAMIDINE; PHENYTOIN; PROTEINASE INHIBITOR; RIFAMPICIN; STAVUDINE; SULFAMETHOXAZOLE; TRIMETHOPRIM; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BONE MARROW TOXICITY; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; ELECTROLYTE DISTURBANCE; ENDOCRINE DISEASE; FATIGUE; GASTROINTESTINAL DISEASE; HEADACHE; HEART ARRHYTHMIA; HEMATOLOGIC DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOPATHOLOGY; INFECTION RISK; KIDNEY DISEASE; LIVER DISEASE; MACROCYTIC ANEMIA; MALAISE; MUSCULOSKELETAL DISEASE; NAUSEA; NEUROLOGIC DISEASE; NEUTROPENIA; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PREGNANCY; PRIORITY JOURNAL; REGIONAL ANESTHESIA; RESPIRATORY TRACT DISEASE; THROMBOCYTOPENIA; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UNITED STATES; VOMITING;

EID: 0038075482     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(03)00029-1     Document Type: Conference Paper

References (87)

1. Adhieh L. Pregnancy and infection with human immunodeficiency virus. Clin Obstet Gynecol. 44:2001;154-166.
2. Gottlieb M.S., Schroff R., Schanker H.M., et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men Evidence of a new acquired cellular immunodeficiency . N Engl J Med. 305:1981;1425-1431.
3. Hughes S.C. AIDS the focus turns to women . Intl J Obstet Anesthesiol. 2:1993;1-2.
4. Greene E.R. Jr. Spinal and epidural anesthesia in patients with the acquired immunodeficiency syndrome. Anesth Analg. 65:1986;1090-1091.
5. Kuczkowski K.M., Benumof J.L. Cesarean section in the parturient with HIV and recent cocaine and alcohol intake anesthetic implications . Intl J Obstet Anesthesiol. 11:2002;135-137.
6. Hughes S.C. Human immunodeficiency virus and obstetric anesthesia. Anesthesiol Clin No Am. 16:1998;397-418.
7. Kuczkowski K.M., Birnbach D.J. The HIV-infected parturient is neuraxial anesthesia contraindicated? Curr Anesthesiol Rep. 2:2000;118-121.
8. Hughes S.C., Dailey P.A., Landers D., Dattel B.J., Crombleholme W.R., Johnson J.L. Parturients infected with human immunodeficiency virus and regional anesthesia. Clinical and immunologic response. Anesthesiology. 82:1995;32-37.
9. Avidan M.S., Groves P., Blott M., et al. Low complication rate associated with cesarean section under spinal anesthesia for HIV-1-infected women on antiretroviral therapy. Anesthesiology. 97:2002;320-324.
10. Gershon R.Y., Manning-Williams D. Anesthesia and the HIV-infected parturient a retrospective study . Intl J Obstet Anesthesiol. 6:1997;76-81.
11. Kuczkowski K.M., Birnbach D.J., van Zundert A. Drug abuse in the parturient. Semin Anesthesiol Periop Med Pain. 19:(3):2000;216-224.
12. WHO Geneva, Weekly Epidemiological Record. 1997;27:197-200.
13. UNAIDS. 2000. Report on the global HIV/AIDS epidemic. UNAIDS, Geneva, Switzerland, 2000.
14. Mann J.M., Taratola D.J.M., Netter T.W. The HIV pandemic status and trends . Mann J.M., Tarantola D.J., Netter T.W. AIDS in the World. 1992;Harvard University Press, Cambridge, MA.
15. Newman M.D., Wofsy C.B. Gender-specific issues in HIV disease. Sande M.A., Volberding P.A. The Medical Management of AIDS. 1997;475-490 W. B. Saunders, Philadelphia.
16. Update: Mortality attributable to HIV infection among persons ages 25-44 years - United States, 1996. From the Centers for Disease Control. Morbit Mortal Wkly Rep MWR 45:121-5.
17. Singh U., Rocke D.A. Acquired immunodeficiency syndrome and obstetric anesthesia. Birnbach D.J., Gatt S.P., Datta S. Textbook of Obstetric Anesthesia. 2000;668-684 Churchill Livingstone, New York.
18. Levy J.A. HIV pathogenesis and long-term survival. AIDS. 7:1993;1401-1410.
19. Fauci A.S., Lane H.C. Human immunodeficiency virus (HIV) disease AIDS and related disorders . Isselbacher K.J., et al. Harrison's Principles of Internal Medicine. 1994;1852-1913 McGraw-Hill, New York.
20. Fauci A.S. The human immunodeficiency virus infectivity and mechanism of pathogenesis . Science. 239:1988;617-622.
21. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. MMWR No RR7, May 17, 2002;51.
22. Layon A.J., Peck A.B. Anesthetic effects on immune function where do we stand? Stoelting R.K., Barash P.G., Gallagher T.J. Advances in Anesthesia. 10:1993;69-93 Mosby, St. Louis.
23. Landers D.V., Martinez de Tejada B., Coyne B.A. Immunology of HIV and pregnancy. The effects of each on the other. Obstet Gynecol Clin No Am. 24:1997;821-831.
24. Haynes B.F., Pantaleo G., Fauci A.S. Toward an understanding of the correlates of protective immunity to HIV infection. Science. 271:1996;324-328.
25. Saag M.S. Quantitation of HIV viral load A tool for clinical practice? Sande M.A., Volberding P.A. The Medical Management of AIDS. 1997;57-74 W. B. Saunders, Philadelphia.
26. Ogilvie G., Adsett S., MacDonald G. Do physicians discuss HIV testing during prenatal care? Can Fam Physician. 43:1997;1376-1381.
27. King J.C. Substance abuse in pregnancy. A bigger problem than you think. Postgrad Med. 102:1997;135-137. p 140-5, 149-50.
28. Kuczkowski K.M. Cocaine abuse in pregnancy - anesthetic implications. Intl J Obstet Anesthesiol. 11:2002;204-210.
29. Minkoff H., de Regt R.H., Landesman S., Schwarz R. Pneumocystis carinii pneumonia with acquired immunodeficiency syndrome in pregnancy a report of three maternal deaths . Obstet Gynecol. 67:1986;284-287.
30. Stansell J.D., Huang L. Pneumocystis carinii pneumonia. Sande M.A., Volberding P.A. The National Management of AIDS. 1997;275-300 W. B. Saunders, Philadelphia.
31. Wachter R.M., Russi M.B., Bloch D.A., Hopewell P.C., Luce J.M. Pneumocystis carinii pneumonia and respiratory failure in AIDS improved outcomes and increased use of intensive care units . Am Rev Respir Dis. 143:1991;251-256.
32. Bozzette S.A., Sattler F.R., Chiu J., et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med. 323:1990;1452-1457.
33. Hopewell P.C. Tuberculosis in persons with human immunodeficiency virus infection. Sande M.A., Volberding P.A. The Medical Management of AIDS. 1997;311-325 W. B. Saunders, Philadelphia.
34. Gayle H.D., Hill G.L. Global impact of human immunodeficiency virus and AIDS. Clin Microbiol Rev. 14:2001;327-335.
35. Dye C., Scheele S., Dolin P., Pathina V., Raviglione M.C. Consensus statement. Global burden of tuberculosis estimated incidence, prevalence, and mortality by country WHO Global Surveillance and Monitoring Project . JAMA. 282:1999;677-686.
36. Horsburgh C.R. Jr. Advances in the prevention and treatment of Mycobacterium avium disease. N Engl J Med. 335:1996;428-430.
37. Denning D.W., Anderson J., Rudge P., Smith H. Acute myelopathy associated with primary infection with human immunodeficiency virus. Br Med J (Clin Res Ed). 294:1987;143-144.
38. Kanzer M.D. Neuropathology of AIDS. Crit Rev Neurobiol. 5:1990;313-362.
39. Birnbach D.J., Bourlier R.A., Choi R., Thys D.M. Anesthetic management of caesarean section in a patient with active recurrent genital herpes and AIDS-related dementia. Br J Anaesth. 75:1995;639-641.
40. Leger J.M., Bouche P., Bolgert F., et al. The spectrum of polyneuropathies in patients infected with HIV. J Neurol Neurosurg Psychiatr. 52:1989;1369-1374.
41. Ochechukwu C.N., Ross J. Hodgkin's lymphoma in a pregnant patient with acquired immunodeficiency syndrome. Clin Oncol. 10:1998;410-411.
42. Cello J.P. Gastrointestinal tract manifestations of AIDS. Sande M.A., Volberding P.A. 1997;181-195 W. B. Saunders, Philadelphia. The Medical Management of AIDS.
43. Cheitlin M.D. Cardiovascular complications of HIV infection. Sande M.A., Volberding P.A. The Medical Management of AIDS. 1997;247-256 W. B. Saunders, Philadelphia.
44. Carmmarosano C., Lewis W. Cardiac lesions in acquired immune deficiency syndrome (AIDS). J Am College Cardiol. 5:1985;703-706.
45. Anderson D.W., Virmani R. Emerging patterns of heart disease in human immunodeficiency virus infection. Human Pathol. 21:1990;253-259.
46. Rao T.K., Filippone E.J., Nicastri A.D., et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med. 310:1984;669-673.
47. Weinberg E.D. Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis. 6:1984;814-820.
48. Barnett M.A., Learmonth R.P., Pilh E., Johnson W.R., Barnett M.A., McDermott F.T., Hughes E.S. T-helper lymphocyte depression in early human pregnancy. J Reprod Immunol. 5:1983;55-59.
49. Coulam C.B., Silverfield J.C., Kazmar R.E., Fath C.G. T lymphocyte subsets during pregnancy in the menstrual cycle. Am J Reprod Immunol. 4:1983;88-90.
50. +, and CD8+ lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women. Obstet Gynecol. 89:1997;967-974.
51. Membreno L., Irony I., Dere W., Klein R., Biglieri E.G., Cobb E. Adrenocortical function in the acquired immunodeficiency syndrome. J Clin Endocrinol Metabol. 65:1987;482-487.
52. Schaubelan M., Sellmeyer D.E., Grunfeld C. Endocrinologic manifestations of IV infection. Sande M.A., Volberding P.A. The Medical Management of AIDS. 1997;257-267 W. B. Saunders, Philadelphia.
53. Thea D.M., Steketee R.W., Pliner V., et al. The effect of maternal viral load on the risk of perinatal transmission of HIV-1. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS. 11:1997;437-444.
54. Stratton P., Tuomala R.E., Abboud R., et al. Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women a report of the women and infants transmission study . J Acquir Immune Defic Syndr Hum Retrovirol. 20:1999;179-186.
55. Mock P.A., Shaffer N., Bhadrakom C., et al. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand Bangkok Collaborative Perinatal HIV Transmission Study Group. AIDS. 13:1999;407-414.
56. Resnick L., Berger J.R., Shapshak P., Tourtellote W.W. Early penetration of the blood-brain-barrier by HIV. Neurology. 38:1988;9-14.
57. Minkoff HL, Henderson CE, Willoughby A: The influence of HIV serostatus on pregnancy outcome: results of prospective case control study. In Proceedings of the Society of Perinatal Obstetricians, 10th Meeting, Houston, Texas. 1990:157-64.
58. Landesman S.H., Kalish L.A., Burns D.N., et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. N Engl J Med. 334:1996;1617-1623.
59. St. Louis M.E., Kamenga M., Brown C., et al. Risk of perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA. 269:1993;2853-2859.
60. American College of Obstetricians and Gynecologists, 2000. Scheduled Cesarean Delivery and the Prevention of Vertical Transmission of HIV Infection. Washington, DC. American College of Obstetricians and Gynecologists, 2000 Committee Opinion, Number 234.
61. Kind C., Rudin C., Siegrist C.A., et al. Prevention of vertical HIV transmission additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group . AIDS. 12:1998;205-210.
62. Scarrow S.E. Obstetrical delivery of the HIV-positive woman legal and ethical considerations . Obstet Gynecol Surv. 56:2001;178-183.
63. Ibe M., Knolle P., Beck T., Meyer zum Buschenfelde K.H., Gerken G. HIV and pregnancy risks of transmission and therapeutic possibilities . Gynakol Geburtshilfliche Rundsch. 36:1996;188-193.
64. Dunn D.T., Newell M.L., Ades A.E., Peckham C.S. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 340:1992;585-588.
65. Burke D.S. Recombination in HIV an important viral evolutionary strategy . Emerg Infect Dis. 3:1997;253-259.
66. Watts D.H. Maternal therapy for HIV in pregnancy. Clin Obstet Gynecol. 44:2001;182-197.
67. http://www.cdc.gov.
68. http://www.aids.org.
69. http://www.hivatis.org.
70. Volberding P.A. Antiretroviral therapy. Sande M.A., Volberding P.A. Medical Maanagement of AIDS. 1997;113-124 W. B. Saunders, Philadelphia.
71. Lee B.I. Drug interactions and toxicities in patients with AIDS. Sande M.A., Volberding P.A. 1997;125-142 W. B. Saunders, Philadelphia. The Medical Management of AIDS.
72. Dube M.P. Hyperglycemia a possible late side effect of protease inhibitors. Lancet. 350:1997;713-714.
73. Hankins C., Tran T., Lapointe N. Sexual behavior and pregnancy outcome in HIV infected women. Canadian Women's HIV Study Group. J Acquir Immun Defic Syndr Hum Retrovirol. 18:1998;479-487.
74. Centers for Disease Control and Prevention. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of the antiretroviral agents in HIV-infected adults and adolescents. MMWR Morb Mort Wkly Rep 1998;(RR-5):1-82. Updated January 2000.
75. Human Immunodeficiency Virus Ethical Guidelines for Obstetricians and Gynecologists . 2001;American College of Obstetricians and Gynecologists, Washington, DC. Committee Opinion, Number 255.
76. Recommendations for Infection Control for the Practice of Anesthesiology. 1998;American Society of Anesthesiologists, Park Ridge, IL.
77. Folkers G.K., Fauci A.S. The role of US government agencies in vaccine research and development. Nat Med. 4:(Suppl 5):1998;491-494.
78. Kuczkowski KM, Benumof JL: Amphetamine abuse in pregnancy: anesthetic implications. Acta Anaesthesiol Belg (in press).
79. Tom D.J., Gulevich S.J., Shapiro H.M., Heaton R.K., Grant I. Epidural blood patch in the HIV-positive patient. Review of clinical experience. San Diego HIV Neurobehavioral Research Center. Anesthesiology. 76:1992;943-947.
80. Olkkola K.T., Palkama V.J., Neuvonen P.J. Ritonavir's role in reducing fentanyl clearance and prolonging its half-life. Anesthesiology. 91:1999;681-685.
81. Kristensen M.S., Sloth E., Jensen T.K. Relationship between anesthetic procedure and contact of anesthesia personnel with patient body fluids. Anesthesiology. 73:1990;619-624.
82. Katz M.H., Gerberding J.L. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use. N Engl J Med. 336:1997;1097-1100.
83. Gerberding J.L. HIV transmission to providers and their patients. Sande M.A., Volberding P.A. 1997;54-64 W. B. Saunders, Philadelphia. The Medical Management of AIDS.
84. Gerberding J.L. Management of occupational exposures to blood-borne viruses. N Engl J Med. 332:1995;444-451.
85. Centers for Disease Control. Case control study of HIV seroconversion in health care workers after percutaneous exposure to HIV infected blood. France, United Kingdom and United States, January 1998-August 1994 MMWR.
86. Coates T.J., Collins C. Preventing HIV infection. Sci Am. 279:1998;96-97.
87. Hughes S.C., Dailey P.A. Human immunodeficiency virus in the delivery suite. Hughes S.C., Levinson G., Rosen M.A. 4th ed:2002;583-595 Lippincott Williams & Wilkins, Philadelphia. Shnider and Levinson's Anesthesia for Obstetrics.